A carregar...
VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects
Despite setbacks, the clinical development of antiangiogenic agents has accelerated remarkably over the past 3–4 years. Consequently, there are currently three direct inhibitors of the VEGF pathway approved for use in cancer therapy. Other agents that block the VEGF pathway are in advanced stages of...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2686126/ https://ncbi.nlm.nih.gov/pubmed/17462954 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmed.2007.04.001 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|